The largest database of trusted experimental protocols

Ca 074 me

Manufactured by Merck Group
Sourced in United States

CA-074 Me is a laboratory reagent produced by Merck Group. It is a cathepsin B inhibitor with a core function of inhibiting the enzymatic activity of cathepsin B. No further details on intended use are provided.

Automatically generated - may contain errors

38 protocols using ca 074 me

1

Investigating Cellular Responses to Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ODN2088 (Invitrogen), in vivo ODN2088 (50 μg/mouse) was administrated via tail vein prior to instillation of mtDNA, and in vitro ODN2088 (25 μg) was added in the medium prior to mtDNA treatment. For CA074 Me (Millipore), in vitro MH-S cells were pre-treated with CA074 Me (100 μM, 40 μg) for 30 min before stimulation and then treated with CBNPs (100 µg/cm2) for 30 min with the presence of CA074 Me, and in vivo CA074 Me (40 μg/mouse) was administrated via tail vein 2 h prior to instillation of CBNPs. For SB 203580 (Sigma), in vivo SB 203580 (3.77 μg/mouse) was administrated via tail vein prior to instillation of CBNPs.
+ Open protocol
+ Expand
2

Carotid Endothelial Cell Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse carotid arterial endothelial cells were isolated and characterized as described earlier [20 (link), 21 (link)]. For the TMAO stimulation, cells were treated with TMAO (30 μm) and then incubated for overnight. In case of inhibitors used, the cells were pretreated with 1 mmol/L Z-WEHD-FMK (WEHD; R&D Systems, Minneapolis, MN), cathepsin B inhibitor Ca-074Me (5 μM, Sigma), potassium channel blocker glibenclamide (Glib, 10 μM, Sigma) or ROS scavenger N-acetyl-L-cysteine (NAC, 10 μM, Sigma) for 30 min.
+ Open protocol
+ Expand
3

Isolation and Activation of Hepatic Stellate Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolation of hepatic stellate cells, 24 week old female or male mice were used. Briefly; mice were anesthetized by ketamine/xylazine injection and perfused in situ through the inferior vena cava with sequential Pronase E (0.4 mg/ml) and Collagenase D (0.8 mg/ml) solutions. Liver was removed and digested in vitro with Collagenase D (0.5 mg/ml), Pronase E (0.5 mg/ml) and DNAse I (0.02 mg/ml). After 20 minutes, tissue was filtered through a 70 μm mesh. Cells were separated using a Nycodenz gradient centrifugation. The HSC were sorted by gating for tomato positive signaling or seeded into plastic tissue culture flasks in DMEM containing fetal serum, and incubated at 37 °C with CO2 overnight. In order to deplete any macrophage contamination, HSC layer was treated with clodronate liposomes (5mg/ml) for 4 h at 37°C as previously described (15 (link)). The next morning, the culture medium was changed and inflammasome activation in HSC was induced with LPS (1 μg/ml) for 3 h and either adenosine triphosphate (ATP) (5 mM) for 1 h or with 4-hydroxytamoxifen (4-OH Tamoxifen), the active metabolite of tamoxifen, for 24 h. In addition, HSC were co-incubated with CA-074 –Me (20 μM) (Sigma Aldrich) to inhibit Cathepsin B activity. In an independent experiment, HSC were stimulated with TGF-β (100 ng/ml) for 4 h.
+ Open protocol
+ Expand
4

Fungal Infection of Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived macrophages derived from wild-type (WT) or knockout mice were infected with F. pedrosoi for 6 (RT-qPCR analysis) and 24 h (other assays) at a multiplicity of infection (MOI) of 3 for conidial infection (except for fungicidal assays, performed with a MOI of 1) and of 1 for hyphal. For inhibition assays, BMDMs received 2 h prior to the infection a Myd88 inhibitor peptide (50 µM) (InvivoGen), Syk inhibitor R406 (5 µM) (InvivoGen), NF-kB inhibitor celastrol (5 µM) (InvivoGen), caspase-1 inhibitor AC-YVAD-CHO (50 µM) (Santa Cruz Biotechnology), caspase-8 inhibitor Z-IETD-FMK (50 µM) (Santa Cruz Biotechnology), intracellular potassium efflux inhibitors glyburide (150 µM) (InvivoGen) and KCl (50 mM) (Sigma-Aldrich), ROS inhibitor DPI (diphenyleneiodonium chloride) (20 µM) (Sigma-Aldrich), endosomal acidification inhibitor bafilomycin A (250 nM) (InvivoGen) or cathepsin B inhibitor CA-074 Me (50 µM) (Sigma-Aldrich). In some experiments, BMDMs and BMDCs were treated 2 h previously to the fungal infection with 500 ng/mL of LPS (Sigma-Aldrich) and/or 20 µM of nigericin (InvivoGen) during the last 40 min of incubation (1 h for fungicidal assays). Cells stimulated with both LPS and nigericin served as a positive control for NLRP3-mediated inflammasome activation.
+ Open protocol
+ Expand
5

Inhibiting Tumor Growth in 3D Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
For treatment of MAME cultures with IL-6 nAb (R&D Systems, AF-206-NA), we added 1 μg/ml of IL-6 nAb in the 2 % Cultrex overlay to 3D cultures on the first day of culture and refreshed with IL-6 nAb and 2 % overlay every 4 days. The antibody concentration was selected based on preliminary studies in which we determined the lowest concentration needed to inhibit growth of tumor structures. Oxymatrine (Sigma, St. Louis, MO) at 1-mg/ml (3.7 mM) was added 24 hours after cell seeding and was replaced with fresh drug every 4 days. The Oxymatrine concentration was determined empirically based on the concentration at which proliferation was inhibited to 50 % of control. The protease inhibitors CA074Me and E64d (Sigma, St. Louis, MO) were used at a concentration of 10 μM [35 (link)].
+ Open protocol
+ Expand
6

Cathepsin Inhibitors and Viral Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
GCDCA and chloroquine were purchased from Sigma-Aldrich (St Louis, MO). Cathepsin L inhibitors, Z-FY-CHO and MDL28170, were purchased from Santa Cruz Biotech (Santa Cruz, CA), and a cathepsin B inhibitor CA074-Me was purchased from Sigma-Aldrich. Recombinant human cathepsin L and cathepsin B were purchased from R & D systems (Minneapolis, MN). The primary antibodies used in this study were anti-PEC/Cowden antibodies raised in swine (Chang et al., 2005 (link)), anti-PEC VP2 antibodies raised in guinea pig (Chang et al., 2005 (link)), anti-FCV antibodies raised in guinea pig (Sosnovtsev and Green, 1995 (link)), anti-MNV-1 antibodies raised in guinea pig (Wobus et al., 2004 (link)) and anti-Rab7 antibodies (Santa Cruz Biotech, CA). The secondary antibodies for Western blot analysis included horseradish peroxidase-conjugates of anti-swine Ig and anti-guinea pig Ig antibody (Thermo Scientific, Pittsburgh, PA). The secondary antibodies for confocal microscopy were FITC-labeled anti-swine IgG for PEC (Kirkegaard & Perry Lab Inc, MD), FITC-labeled anti-guinea pig IgG for MNV-1 (Sigma-Aldrich, MO) and anti-rabbit PerCP-Cy 5.5 (Santa Cruz Biotech, CA). Other basic chemicals for confocal microscopy and other studies were purchased from various sources including Sigma-Aldrich.
+ Open protocol
+ Expand
7

Inflammatory Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deoxycholic acid (DCA), lipopolysaccharide (LPS), CA-074 Me, and JTE-013 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dextran sulfate sodium (DSS, molecular weight 36–50 kDa) was obtained from MP Biomedicals Inc. (Irvine, CA, USA). ASC antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). IL-1β, ERK, AKT antibodies, and U0126 were purchased from Cell Signaling Technologies (Beverly, MA, USA). DMEM and RPMI 1640 were obtained from Invitrogen (Carlsbad, CA, USA). ELISA Kits were from eBioscience (San Diego, CA, USA).
+ Open protocol
+ Expand
8

Dendritic Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The commercial sources for reagents were as follows: CpG oligodeoxynucleotide ODN2216 (Invivogen); chloroquine, bafilomycin A1 and CA-074-Me (Sigma-Aldrich); Flt3L (R & D systems); anti-mouse CD11c APC (BD Pharmingen), anti-mouse B220 APC-Cy7 and anti-mouse PDCA-1 PE (Milteny Biotec); and Phosphonoacetate (Sigma).
+ Open protocol
+ Expand
9

Blocking Cytotoxic Effects of Autoantibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Agents used to block the cytotoxic activity of aAb were as follows: caspase 3 inhibitor Ac-DEVD-CHO (5 μM), caspase 8 inhibitor Ac-IEID-CHO (5 μM), RIP1 kinase inhibitor necrostatin 1 (5 μM), RIP3 kinase inhibitor GSK 872 (5 μM), chloroquine (5 μM), NSA (5 μM), EGTA (2 μM), ionol (1 μM), Necrox-2 (1 μM), cathepsin B inhibitor Ca-074Me (10 μM), cathepsin D inhibitor Pepstatin A (10 μM), calpain inhibitor peptide (10 μM) (all from Sigma–Aldrich), STAT3 inhibitor Stattic-V (10 μM), and phospholipase C inhibitor cPLA2 (1 μM) (both from Santa-Cruz). All these agents were added 1 h prior to cell incubation with aAb.
+ Open protocol
+ Expand
10

Inflammatory Pathways Modulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipopolysaccharide (LPS), Chenodeoxycholic acid (CDCA), CA-074 Me, Tyrphostin AG 1478, A438079 and N-acetyl-L-cysteine (NAC) were purchased from Sigma-Aldrich (St. Louis, MO). SQ22536 was obtained from Abcam (Cambridge, MA). Cytochalasin D and Z-Guggulsterone were purchased from Santa cruz Biotechnology (Santa cruz, CA). VX-765 (belnacasan) and MK-2206 were purchased from Selleck ( Houston, TX). SP600125 and U0126 were obtained from Cell Signaling Technologies (Beverly, MA). RPMI 1640, DMEM and antibiotics were obtained from Invitrogen (Carlsbad, CA). 2’, 7’-dichlorofluorescein diacetate (DCF-DA) were from Invitrogen/Molecular Probes. ELISA Kits were purchased from eBioscience (San Diego, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!